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ABSTRACT
Double-stranded RNA (dsRNA) can enter different
pathways in mammalian cells, including sequence-
specific RNA interference (RNAi), sequence-
independent interferon (IFN) response and editing
by adenosine deaminases. To study the routing of
dsRNA to these pathways in vivo, we used transgen-
ic mice ubiquitously expressing from a strong pro-
moter, an mRNA with a long hairpin in its 30-UTR.
The expressed dsRNA neither caused any develop-
mental defects nor activated the IFN response,
which was inducible only at high expression levels
in cultured cells. The dsRNA was poorly processed
into siRNAs in somatic cells, whereas, robust RNAi
effects were found in oocytes, suggesting that
somatic cells lack some factor(s) facilitating siRNA
biogenesis. Expressed dsRNA did not cause tran-
scriptional silencing in trans. Analysis of RNA editing
revealed that a small fraction of long dsRNA is edited.
RNA editing neither prevented the cytoplasmic lo-
calization nor processing into siRNAs. Thus, a long
dsRNA structure is well tolerated in mammalian cells
and is mainly causing a robust RNAi response in
oocytes.
INTRODUCTION
Double-stranded RNA (dsRNA), a double helix formed
by two antiparallel RNA strands, is a unique structure
whose recognition is important in host defense and regu-
lation of gene expression. The recognition and effects of
dsRNA are mediated by a diverse set of proteins
harboring dsRNA binding domains (dsRBD), [reviewed
in Ref. (1)].
One of the evolutionarily conserved effects of dsRNA is
represented by RNA interference (RNAi), sequence-
speciﬁc degradation of RNAs complementary to the se-
quence of the dsRNA [reviewed in Ref, e.g. (2,3)]. RNAi is
initiated by the RNase III enzyme Dicer, which is cleaving
dsRNA at 21 nt intervals, generating short interfering
RNA (siRNA) duplexes with two nucleotide 30 overhangs.
One of the siRNA strands is loaded onto the RNA-
induced silencing complex (RISC), where it serves as a
guide for cleaving perfectly complementary mRNAs. In
mammalian cells, RNAi effects can also be induced experi-
mentally by siRNAs (4) or by microRNAs (5). Endogenous
microRNAs (miRNAs) are genome-encoded small RNAs
produced by cleavage of pre-processed short hairpin pre-
cursors by Dicer and are also loaded on a RISC-like
complex [reviewed in Ref. (6)]. For the purpose of this
study, we use the term RNAi for the pathway that is
induced by long dsRNA, i.e. as it was originally described
by Fire et al. (7). RNAi operates in most eukaryotes and
often serves as a defense mechanism against viruses and
repetitive sequences. Hence, it is often viewed as a form of
innate immunity (8). However, RNAi in mammals does
not appear to play an antiviral role (9) and its endogenous
function has only been clearly documented for oocytes
and embryonic stem cells where it targets repetitive elem-
ents and regulates endogenous genes [reviewed in Ref
(10)]. Nevertheless, experimental induction of RNAi
with ectopically expressed long dsRNA in different somat-
ic cells (11–14) suggests capacity for siRNA generation
from dsRNA also in other cell types.
Mammalian somatic cells can respond to dsRNA in a
sequence-independent manner. A pioneering work by
Hunter et al. (15) showed that different types of dsRNA,
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including the poly I:C duplex, can block translation in
reticulocyte lysates. Analysis of this phenomenon ident-
iﬁed protein kinase R (PKR), an enzyme activated upon
binding to dsRNA that blocks translation by phospho-
rylating the a-subunit of eukaryotic initiation factor 2
(eIF-2a) (16). Activation of PKR represents part of a
complex response to foreign molecules known as the inter-
feron (IFN) response [reviewed in Ref (17)], which
includes activation of the NFkB transcription factor and
a large number of IFN-stimulated genes (ISGs) (18). In
addition to PKR, several other proteins recognizing
dsRNA are integrated into the IFN response. DDX58
(RIG-I) and MDA5 sense cytoplasmic dsRNA and acti-
vate IFN expression. The 20,50-oligoadenylate synthetase
produces 20,50-linked oligoadenylates that induce a general
degradation of RNAs by activating latent RNase L
[reviewed in Ref, e.g. (19,20)].
Another dsRNA-associated mammalian pathway is
represented by RNA editing, which is mediated by adeno-
sine deaminases acting on RNA (ADARs). These dsRNA
recognizing enzymes convert adenosines to inosines, thus
affect stability and coding potential of modiﬁed RNAs
[reviewed in Ref (21,22)]. The effects of dsRNA editing
are complex and the degree of editing may affect the sub-
sequent fate of the edited RNA, leading to its nuclear re-
tention (23) or degradation (24). Nevertheless, mRNAs
carrying edited dsRNA hairpins in their 30-UTR can be
transported to the cytoplasm and translated, as evidenced
by the presence of such mRNAs on polysomes (25).
Editing of long dsRNA in Caenorhabditis elegans antag-
onizes the transgene-induced RNAi in somatic cells by re-
taining edited dsRNA in the nucleus (26). However, the
reported role of the cytoplasmic RISC component Tudor-
SN in the degradation of hyperedited RNAs (>50% con-
version) indicates more complex interplay between editing
and RNAi (24). Mammalian ADARs can reduce efﬁciency
of RNAi in two ways. First, they can erode dsRNA to the
point where it is either no longer a suitable substrate for
Dicer processing or, in the case of successful Dicer
cleavage, the resulting siRNAs have changed speciﬁcity
to base pair with target mRNAs. Second, they can reduce
availability of siRNAs by directly binding to them, an
effect that seems to be independent of ADAR editing
activity (27,28).
While the three main mammalian dsRNA-responding
pathways mentioned above have been individually
characterized in substantial detail, the interactions
between them are still poorly understood. Co-existence
of these pathways certainly involves recognition of differ-
ent types of dsRNA substrates and their possible seques-
tration in different cellular compartments or cell types
[reviewed in Ref (19,29)]. The latter phenomenon under-
lies the common simplistic view that cytoplasmic dsRNA
is toxic to somatic cells because it activates the IFN
response, while nuclear dsRNA is edited and thus pre-
vented to enter the cytoplasm. However, such interpret-
ation is challenged by the growing list of reports showing
induction of RNAi by intracellular expression of
long dsRNA in transformed and primary somatic cells
(4,11–13,30,31).
To obtain new insights into the effects of dsRNA in
various types of somatic cells, we produced a transgenic
mouse model ubiquitously expressing long dsRNA. We
have previously developed a transgene that generates
dsRNA within the 30-UTR of a protein-coding transcript.
This dsRNA takes the form of a long hairpin with a
perfect 0.5 kb stem, which is ﬂanked by long single-
stranded 50 and 30 overhangs. Using a transgene with the
Mos gene sequence in the hairpin and oocyte-speciﬁc ZP3
promoter, we induced an efﬁcient and highly speciﬁc
RNAi effect in mouse oocytes (32,33). Physiologically,
the Mos gene encodes for a dormant maternal mRNA,
which is stored in the oocyte until the resumption of
meiosis (34). Elimination of the Mos maternal mRNA
by transgenic RNAi phenocopies the null mutation (32),
which manifests as parthenogenetic activation of ovulated
eggs and ovarian cysts. Otherwise,Mos/ animals appear
normal (35,36).
Here, we report an adaptation of theMos hairpin trans-
gene (for simplicity referred to as MosIR) for ubiquitous,
constitutive expression of dsRNA in transgenic mice. We
show that in somatic cells of transgenic animals, dsRNA
does not induce the IFN response, is inefﬁciently pro-
cessed by Dicer and its editing is barely detectable. This
suggests that a long dsRNA structure embedded in a tran-
script produced by RNA polymerase II in the nucleus of
somatic cells is not a potent trigger of any of the three
common pathways responding to dsRNA. When MosIR
RNA levels were increased in cell culture experiments, we
observed more frequent editing while IFN pathway acti-
vation and RNAi effects were still negligible. The IFN
response was induced only with high levels of expressed
dsRNA in somatic cells. In contrast to somatic cells, the
MosIR induced a robust RNAi effect in oocytes suggest-
ing that female germ cells represent a tissue adapted to
directing dsRNA into the RNAi pathway.
MATERIALS AND METHODS
Plasmids and transgenes
Schematic structures of the relevant parts of plasmid con-
structs used in the project are shown in the Supplementary
Figure S1. pCAGEGFP-MosIR (for simplicity, referred to
as MosIR) was produced by transferring the EagI
fragment carrying the Mos inverted repeat inserted in
the pCR II plasmid (37) into the SspBI site downstream
of the enhanced green ﬂuorescent protein (EGFP) coding
sequence in the pCAGEGFP plasmid (38). pCAGEGFP-
Mos3 (for simplicity, referred to as Mos3) was produced
by inserting a PCR-ampliﬁed 973 bp fragment of the Mos
transcript (corresponding to nucleotides 114–1089 of the
Mos cDNA sequence NM020021) into the SspBI site
downstream of the EGFP coding sequence in the
pCAGEGFP plasmid. pCAGEGFP-MosP (for simplicity,
referred to as MosP) was produced by inserting the same
PCR-ampliﬁed 973 bp fragment of theMos transcript into
the SnaBI site between the cytomegalovirus (CMV)
enhancer and b-actin promoter. Insertion into the
pCAGEGFP was veriﬁed by restriction digest and
sequencing. The Mos sequence in Mos3 and MosP
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fragments was inserted in the sense orientation relative to
the EGFP transcription and a KpnI site in the Mos was
eliminated by blunt-ending and re-ligation, allowing for
distinguishable reporter sequences from the endogenous
Mos sequences. EGFP expression from MosP and Mos3
plasmids were compared with the original EGFP plasmid
by ﬂow cytometry (FACS) analysis of HEK293 cells (for
simplicity, referred to as 293) transfected with equimolar
amounts of each plasmid. This analysis showed that, at
similar transfection efﬁciency, Mos3 and MosP EGFP ex-
pression reached 25 and 80% of pCAGEGFP, respect-
ively (data not shown). The lower Mos3 EGFP expression
was probably caused by lower stability or reduced trans-
latability of the EGFP mRNA that was expanded in its
30-UTR by an additional 1 kb of sequence. For each
MosIR, Mos3 and MosP plasmid, SalI and HindIII
were used to release the transgenic cassette for producing
transgenic animals. phRL-TK-Mos3 (for simplicity, re-
ferred to as RL-Mos3) production was described previous-
ly (39). Fireﬂy luciferase (for simplicity, referred to as FF)
served as a non-targeted control.
Transgenic mice
Transgenic mice were generated at the transgenic facility
of the Friedrich Miescher Institute by injecting linearized
DNA into male pronuclei of C57BL/6BALB/c 1-cell
embryos. Transgene-positive mice were identiﬁed by
PCR (primer sequences are listed in the Supplementary
Table SIII). For the MosIR transgene, four different foun-
der animals (one female and three males) were obtained
and examined further. One female founder animal was
sterile and showed the Mos null phenotype [parthenogen-
etic activation of unfertilized oocytes (35,36)]. F1 progeny
of founder males was examined for the expression of
EGFP and down-regulation of Mos mRNA in oocytes.
The line with the strongest Mos null phenotype in
female animals was expanded and used for further
analysis. For Mos3 and MosP reporter lines, founder ani-
mals were crossed with C57BL/6BALB/c animals and
the line with the strongest EGFP expression for each
reporter was used further.
Oocyte isolation and culture
Adult transgenic or wild-type female siblings were super-
ovulated using 5 U of pregnant mare serum gonadotropin
(PMSG, Intervet). Oocytes were isolated as described pre-
viously (40). Images of oocytes and organ samples were
obtained using a digital camera mounted to a stereomicro-
scope SZX16 equipped with a 100W mercury lamp and
GFPA ﬁlter (Olympus).
Cell culture and transfection
Human 293 cells were maintained in Dulbecco’s Modiﬁed
Eagle Medium (DMEM, Invitrogen) supplemented with
10% FCS (Invitrogen), penicillin (100U/ml, Invitrogen)
and streptomycin (100mg/ml, Invitrogen) at 37C and
5% CO2 atmosphere.
For transfection, cells were typically plated on a 24-well
plate, grown to 70% density and transfected using
Turbofect in vitro Tranfection Reagent (Fermentas)
according to the manufacturer’s protocol. Cells were
transfected with 100 ng of both untargeted (FF) and
targeted (RL-Mos3) reporter plasmids and various
amount of MosIR plasmid (50–500 ng per well). The
total amount of transfected DNA was kept constant by
adding pCAGEGFP. After 48 h, cells were washed with
PBS and lysed with the Passive Lysis Buffer (Promega).
Luciferase reporter expression was assessed using the
Dual-Luciferase Reporter Assay (Promega) and
luminiscence intensity was measured by Modulus
Microplate Multimode Reader (Turner Biosystems).
The 293 cells stably expressing both RL-Mos3 and FF
were established by co-transfecting reporter plasmids
with the pPuro selection plasmid carrying puromycin re-
sistance (500 ng of each plasmid per well in a 6-well plate).
To select positive clones, cells were passaged in the
presence of 1.5 mg/ml of puromycin. The positively selected
individual clones were tested for Renilla and ﬁreﬂy
luciferase expression using the Dual-Luciferase Reporter
Assay. Clones yielding luciferase expression similar to that
of the transiently transfected cells were used for further
studies.
Isolation of mouse embryonic ﬁbroblasts
Mouse embryos were isolated at embryonic day 12.5. The
head and internal organs were removed, the torso was
homogenized using a needle under sterile conditions and
subsequently cultured in DMEM supplemented with 10%
FCS, penicillin (100U/ml, Invitrogen), and streptomycin
(100mg/ml, Invitrogen) at 37C and 5% CO2 atmosphere.
Mouse embryonic ﬁbroblasts (MEFs) within the ﬁrst three
passages were used for experiments.
Detection of RNase T1-resistant MosIR RNA
The fraction of MosIR RNA, which folded into dsRNA,
was approximated from the comparison of non-treated
RNA (input) and RNase T1-treated (T1) samples.
MosIR-positive MEFs or 293 cells transfected with 2 mg
of MosIR per well in a 6-well plate were harvested 48 h
post-transfection. The cells were washed twice with PBS,
liberated with a rubber scraper into a 1.5ml tube, and
hypotonically lysed with three volumes of water [experi-
ments where cells were permeabilized with 0.1% Triton
X-100 yielded the same results (data not shown)]. Cell
lysates were incubated with RNase T1 (5000U) for
30min at 37C. Negative-control samples were denatu-
rated at 85C for 5min and immediately placed on ice to
prevent perfect pairing of complementary strands prior to
addition of RNase T1. RNase T1 was inactivated by
phenol–chloroform extraction using the RNA Blue
reagent (Top Bio). DNA was removed by Turbo DNase
(Ambion) treatment. All RNA samples were produced in
the same volume (30ml). If needed, concentration of RNA
recovered after treatment was equalized using Escherichia
coli rRNA (Roche). From each sample, 1 mg of RNA was
then reverse-transcribed using RevertAid M-MuLV
Reverse Transcriptase (Fermentas) and a MosIR-speciﬁc
primer or using Superscript II (Invitrogen) and random
hexamer primers with similar results. Reverse transcript-
ase was omitted in ‘–RT’ samples. cDNA was ampliﬁed
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using Maxima SYBR Green/ROX qPCR Master Mix
(Fermentas) and PCR products were resolved on 1.5%
agarose gel stained with ethidium bromide (Sigma
Aldrich).
Microarray analysis
The 293 and HeLa cell lines were analyzed in duplicates
24 h after transfection with 500 ng/well of the MosIR
plasmid in a 6-well plate. Controls were transfected with
equal amounts of the parental pCAGEGFP plasmid.
Microarray analysis of 5 mg of total RNA per sample
was performed as described previously (41). Principal
component analysis and hierarchical clustering of the
GeneChip Robust Multiarray Averaging (GC-RMA)
normalized data were performed by Partek software
(Partek Inc., USA). The bioconductor Limma package
(42) was used to identify differentially expressed genes
and generate MA plots. The heatmap for IFN-related
gene expression was created using TM4 microarray
software suite (43). Microarray data were deposited in
the NCBI GEO database (GSE27316).
Next generation sequencing
Brain and kidney tissues were obtained from a freshly
sacriﬁced 17-week old transgenic female. HeLa and 293
cells were transfected with 500 ng/well of MosIR plasmid
in a 6-well plate and cells were collected 48 h post-
transfection. Small RNA fractions were isolated using
mirPremier microRNA Isolation Kit (Sigma) according
to the manufacturer’s instructions. RNA concentration
was determined using a Nanodrop 1000 spectrophotom-
eter, and the quality of RNA was checked by 8% poly-
acrylamide gel electrophoresis.
Library construction and deep sequencing of small
RNAs were performed by Seqomics (Szeged, Hungary)
using SOLiD (version 3.0) sequencing platform. For the
bioinformatic analysis, the bar code and 30 adaptor se-
quences were removed from raw sequence reads using an
algorithm requiring at least 3-nt exact matches between
35-nt reads and the adaptor sequence. Sequencing quality
and depth of all samples was comparable (Supplementary
Figure S3, the complete Seqomics Sequencing Report is
available on request). Reads were mapped onto the follow-
ing sequences: miRNA [MirBase release 15; http://www.
mirbase.org/, (44)], tRNA [Genomic tRNA database;
http://lowelab.ucsc.edu/GtRNAdb/, (45)], rRNA [http://
www.arb-silva.de/, (46)] and MosIR plasmid. Only
perfect matches were considered for the ﬁrst round of ana-
lysis. The annotation order was miRNA, tRNA, rRNA
and plasmid sequence. To avoid mapping of some reads to
multiple categories, we removed each read from the dataset
once it was annotated to a particular sequence category.
The remaining reads not matching any RNA sequences
were marked as ‘other’. For RNA (A> I) editing analysis,
‘other’ reads were remapped to the above mentioned
selected sequences allowing for one or more A/G
mismatches. All mapping software used in the analysis
were programmed using the Visual Basic 2010 platform
(Microsoft). Lists of generated 35-nt reads in color-coded
format were deposited in the GEO database (GSE26577).
RNA isolation and quantitative real-time RT–PCR
Oocytes for real-time PCR analysis were washed 3-times
in PBS, placed individually in pure water with 10U of
RiboLock RNase inhibitor (Fermentas) while 0.14 pg/ml
of rabbit globin mRNA (Sigma Aldrich) and 0.2mg/ml of
E. coli rRNA (Roche) was added to act as an external
standard and to inhibit sample RNA degradation by
RNases. Samples were stored at 80C prior to reverse
transcription. Total RNA from organs and cultured cells
was isolated by phenol–chloroform extraction using the
RNA Blue reagent (Top-Bio) according to the manufac-
turer’s instructions. Expression of speciﬁc mRNA was
analyzed by quantitative real-time PCR (qPCR) as
described previously (39). Brieﬂy, 1 mg of total RNA was
reverse transcribed using RevertAid M-MuLV reverse
transcriptase (Fermentas) and random hexanucleotides
(Fermentas). Reverse transcriptase was omitted in
control (RT) samples. The resulting cDNA was diluted
three times with water and a 3 ml aliquot was used as a
template for a 10 ml qPCR reaction. qPCR was performed
on the Mx3000P (Stratagene) or LC480 (Roche) machines
using Maxima SYBR Green qPCR Master Mix
(Fermentas). Hypoxanthine–guanine phosphoribosyl-
transferase (Hprt1) was used as an internal housekeeping
gene control (all primers are listed in the Supplementary
Table SIII). Values of crossing points (CPs) were
evaluated and corrected according to PCR efﬁciency for
each reaction. The statistical signiﬁcance of relative ex-
pression changes of target mRNA levels normalized to a
housekeeping gene was analyzed by the pair-wise ﬁxed
reallocation randomization test using the REST 2008
software (47).
RESULTS AND DISCUSSION
Transgenic mice ubiquitously expressing long dsRNA are
viable
To achieve ubiquitous long dsRNA expression in the
mouse, we employed the same general design
(Figure 1A) that was used for transgenic RNAi in
mouse oocytes (32). To control dsRNA expression, we
chose a strong chimeric promoter composed of the
CMV enhancer and b-actin core promoter (CAG) that
provided efﬁcient, ubiquitous expression in transgenic
mice (48). The MosIR transgene produced an mRNA
that carried an EGFP coding sequence and 30-UTR con-
taining a long dsRNA hairpin of the Mos sequence
(Figure 1B).
The MosIR transgene offered several advantages. First,
the EGFP coding sequence upstream of the Mos hairpin
yields a sufﬁcient amount of green ﬂuorescence to monitor
transgene expression. Second, this RNA efﬁciently folds
into dsRNA upon transcription in vitro (37) and it induces
an efﬁcient and highly speciﬁc RNAi effect in the oocyte
(32,33). Third, theMos null phenotype manifests as a par-
thenogenetic activation of unfertilized eggs (35,36),
providing an easily assayed positive control for RNAi
effects. Fourth, the loss of Mos has no phenotype in
somatic cells (35,36) and Mos mRNA levels are negligible
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in somatic cells (49). Therefore, while RNAi effects can be
conveniently monitored with an appropriate reporter
target, the MosIR is also suitable for studying
sequence-independent effects of dsRNA expression in
either the presence or absence of the target mRNA.
We obtained four MosIR transgenic lines upon
pro-nuclear injection of the MosIR transgene. All of
them showed green ﬂuorescence in all tissues examined,
documenting that the transgene was ubiquitously ex-
pressed (Figure 1C; data not shown). The line derived
from the male founder 317.3 showed the strongest Mos
phenotype in the female progeny and was selected for
detailed analysis of effects caused by MosIR expression.
Transgenic females had reduced fertility. Mating of ﬁve
different females for several weeks resulted in only one
litter of two animals. This was an expected consequence
of parthenogenetic activation caused by RNAi-mediated
down-regulation of Mos mRNA in oocytes (Figure 1E
and F). This effect indirectly demonstrated formation of
MosIR-derived dsRNA in oocytes and was identical to the
results obtained with the oocyte-speciﬁc version of the
MosIR transgene (32,33).
Transmission of the MosIR transgene via the male
germline showed normal Mendelian distribution and an
average litter size of 5.8 (Figure 1D), which did not sig-
niﬁcantly differ from litters of this strain in our mouse
facility. This indicated that the MosIR did not cause
embryonic lethality. Apart from the reduced female fertil-
ity, transgenic mice showed no other apparent phenotype
suggesting the MosIR transcript has no effect on cell
growth or viability. At the same time, observable green
ﬂuorescence in different organs indicated that the
MosIR expression was ubiquitous. The amount of
EGFP ﬂuorescence varied across different organs
(Figure 1C). The brightest signal was found in the brain
and testis and the lowest in the liver and spleen. A similar
pattern of EGFP signal was also observed in organs of
transgenic mice with other EGFP-carrying transgenes
controlled by the same promoter but devoid of the
inverted repeat (38) (Figure 2B). Notably, MosIR trans-
gene generated less EGFP than other transgenes driven by
the CAG promoter (Supplementary Figure S1C).
Transfection of equal amounts of pCAGEGFP and
MosIR plasmids into 293 cells showed discrepancy
between mRNA and EGFP ﬂuorescence in MosIR trans-
fected cells (Supplementary Figure S2A and B) and thus,
suggested that lower EGFP ﬂuorescence in MosIR mice
was caused by lower translatability of the MosIR tran-
script. The MosIR transcript was readily detectable by
qPCR in somatic tissues and its relative abundance
correlated with relative amounts of EGFP ﬂuorescence
among tissues (Supplementary Figure S2C).
Although the Mos null phenotype indicated expression
of dsRNA in the female germline, further evidence that
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the MosIR transcripts formed dsRNA in vivo in somatic
cells was necessary. To assess formation of MosIR
dsRNA in intact cells, we used RNase T1 to degrade
single-stranded RNA prior to RNA extraction from
MEFs derived from the MosIR mice since the extraction
can cause formation of dsRNA that does not exist in vivo
(50). RNase T1-resistant MosIR RNA was analyzed by
qPCR. We successfully ampliﬁed the Mos fragment from
RNase T1-treated samples but not from samples where
secondary RNA structure was disrupted by heat before
RNase T1 digestion (Figure 1G). These results provide
qualitative evidence for the presence of MosIR dsRNA
in intact cells. It remains unclear whether the low yield
RNase T1-resistant RNA (5–10% of the input when
estimated by qPCR) is caused by instability of dsRNA
during T1 treatment or whether it reﬂects reduced forma-
tion of dsRNA from the MosIR transcript. The latter
would suggest that somatic cells actively reduce levels of
dsRNA originating from endogenous transcripts, either at
the level of RNA binding proteins, which prevent dsRNA
formation and/or by a duplex unwinding activity. In any
case, our data show that the MosIR transgene is ubiqui-
tously transcribed, triggers RNAi in oocytes and generates
dsRNA in MEFs derived from transgenic mice. This con-
clusion is also supported by evidence provided by experi-
ments presented further below, which show that the
MosIR RNA is edited and processed into siRNAs in
somatic cells.
MosIR transcript efﬁciently enters the RNAi pathway
only in oocytes
The MosIR transcript efﬁciently entered the RNAi
pathway in oocytes as evidenced by the reduction of
Mos mRNA and presence of the Mos null phenotype in
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MosIR mice (Figure 1E and F). As Mos is not expressed
in somatic tissues (49), we produced a transgenic EGFP
reporter carrying the Mos sequence in the 30-UTR
(Figure 2A), allowing us to monitor RNAi effects in
mouse tissues by microscopy. The Mos3 transgene
produced bright EGFP ﬂuorescence, which was stronger
than that of the MosIR (Figure 2B), allowing for rapid
identiﬁcation of RNAi effects. In any case, the fact that
both transgenes produced EGFP was not an obstacle for
studying RNAi effects since the expression of MosIR and
Mos3 transgenes could be distinguished by qPCR.
With the exception of oocytes, where EGFP ﬂuores-
cence was reduced, examination of EGFP ﬂuorescence in
whole organs or in organ cryosections did not reveal any
obvious RNAi effect when samples from mice carrying
both MosIR and Mos3 transgenes were compared to
samples from mice carrying the Mos3 transgene alone
(Figure 2B; data not shown). Likewise, analysis of the
Mos3 transcript level by qPCR did not suggest the occur-
rence of robust somatic RNAi (Figure 2C). Although we
did observe relative reduction of the Mos3 RNA in kidney
and liver samples, this was much less profound compared
with oocytes and may have been a result of tissue
heterogeneity.
To further address the potential of the MosIR dsRNA
to induce RNAi in somatic cells, we performed experi-
ments in cultured cells. 293 cells carrying stably integrated
non-targeted FF and targeted Renilla luciferase
(RL-Mos3) reporters were transfected with increasing
doses of the MosIR transgene that lead to proportionally
increasing levels of MosIR RNA (Supplementary Figure
S2A). However, even in cells with the highest expression of
MosIR, no statistically signiﬁcant RNAi effect was found
(Figure 2D). Furthermore, we did not observe signiﬁcant
RNAi effects upon transient transfection of the MosIR
transgene and both luciferase reporters into 293, HeLa,
or MCF-7 cells (data not shown).
To directly address whether the MosIR RNA enters the
RNAi pathway, we analyzed kidney and brain for the
presence of MosIR-derived siRNAs using high through-
put sequencing by the SOLiD technology (sequencing
depth 4 106 reads). Kidney and brain samples were
selected because both tissues showed high MosIR expres-
sion and kidney samples also showed somewhat reduced
levels of the Mos3 reporter. SOLiD sequencing of tissue
samples produced a distinct peak of 21–23 nt small RNAs,
the size expected for Dicer products (Supplementary
Figure S3A). The number of putative Mos siRNAs was
minimal (20 in the brain and 4 in the kidney). This con-
trasted with hundreds of thousands of potential Dicer
cleavage products, including 70 000 sequences derived
from the three most abundant miRNAs (Figure 3A).
Notably, only one putative siRNA sequence derived
from the single-stranded EGFP region of the MosIR tran-
script was found in each organ sample. Since virtually all
Mos sequences in the brain and kidney samples were in the
range of Dicer products (Figure 3A), we concluded that a
small fraction of MosIR RNA was processed by Dicer
into siRNAs in somatic tissues but their abundance was
too low to cause a robust RNAi effect.
To further address MosIR dsRNA conversion into
siRNA, we performed SOLiD sequencing of small RNA
from 293 cells transiently transfected with high dose of
MosIR plasmid. SOLiD sequencing yielded 343 putative
Mos siRNAs (20–23 nt long), which localized along the
predicted MosIR dsRNA and were enriched among
small RNAs of 17–25 nt in length (Figure 3B and C).
Interestingly, mapping of small RNAs onto the trans-
fected plasmid revealed a complex picture of RNA expres-
sion, including RNA fragments derived from both strands
of EGFP, from the antisense strand of the intron and the
plasmid backbone (Supplementary Figure S3B). This
spurious transcription likely accounts for higher level of
EGFP-derived sequences (434) when compared with the
number of MosIR-derived sequences (343) (Figure 3B).
However, RNAs of the size expected for Dicer products
were not enriched among small RNAs derived from the
EGFP coding sequence (Supplementary Figure S3C)
arguing that the peak of MosIR-derived 21–23 nt se-
quences includes Dicer products. Taking into account the
background of other Mos small RNAs, it appears that
Mos siRNAs could be up to 10 times more abundant in
MosIR-transfected 293 cells than in transgenic tissues,
which likely reﬂects MosIR overexpression in transfected
cell. However, the amount of Mos siRNAs estimated by
SOLiD sequencing in transfected 293 cells was two orders
of magnitude below abundant endogenous miRNAs
(Figure 3B).
Detailed examination of SOLiD results from 293 cells
revealed several thousand EGFP and MosIR sequences
longer than 30 nt, whereas, only one was found in the
brain (Supplementary Figure S3C). Since fragments of
similar length originating from endogenous mRNAs
were not detected (for example, we found only one
fragment from Hprt, a transcript used as an internal
standard for qPCR), the MosIR fragments longer than
30 nt likely represent a snapshot of degradation intermedi-
ates of overexpressed MosIR RNA, rather than artifacts
of sample preparation. Although RNA degradation inter-
mediates would be expected to be much less stable than
siRNAs, we found that putative Mos siRNAs in trans-
fected 293 cells were an order of magnitude less
abundant than the degradation intermediates
(Supplementary Figure S3C). This result is consistent
with the hypothesis that Dicer does not efﬁciently
process MosIR dsRNA into siRNAs in somatic cells.
Since the MosIR transcript caused robust RNAi effects
in oocytes but not in somatic cells, we propose that
oocytes are a privileged tissue for endogenous RNAi in
which dsRNA is efﬁciently presented to Dicer. This model
is consistent with studies reporting abundant endogenous
siRNAs in oocytes (51,52) and few, if any, endogenous
siRNAs in somatic cells (53–56). Nonetheless, our results
do not rule out that other types of long dsRNA molecules
can be processed by Dicer in somatic cells. There are
several reports of RNAi induction with long dsRNA in
somatic cells where long dsRNA was formed by tran-
scripts, which differ from the MosIR RNA (11–14). The
MosIR transcript is a capped and polyadenylated trans-
latable mRNA, which contains long 30-UTR dsRNA stem
and long single-stranded overhangs. These features may
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help the dsRNA to be tolerated in somatic cells and nega-
tively affect processing by Dicer. It was shown that long
single-stranded overhangs can contribute to the reduced
efﬁciency of Dicer processing in vitro (57). Nuclear reten-
tion of edited MosIR dsRNA probably does not signiﬁ-
cantly affect MosIR processing by Dicer. As it will be
discussed further below, RNA editing observed in trans-
genic tissues was below the reported threshold for nuclear
retention. In addition, we have found adenosine-deaminated
MosIR RNA in the polysomal fraction in transgenic
MEFs.
The MosIR expression does not induce transcriptional
silencing
Short RNAs produced by Dicer in some model species
also cause transcriptional silencing by inducing formation
of transcriptionally repressive chromatin [reviewed in Ref
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(58,59)]. Although induction of transcriptional silencing
by siRNAs has been reported for mammals (e.g. 60–62),
the nature of the mechanism is still debated. We have
previously shown that the MosIR transcript does not
induce DNA methylation in the oocyte (63). However,
that experiment was based on oocyte-speciﬁc expression
of dsRNA targeting the endogenous Mos gene coding
sequence and not a promoter, which would be a better
suited target for studying transcriptional silencing. To
address this caveat, we generated another reporter,
named MosP, where the cognate sequence was inserted
into the chimeric promoter, between the CMV enhancer
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Figure 4. MosIR has no effect on transcriptional silencing of cognate sequences. (A) A schematic composition of the MosP reporter transgene. (B)
EGFP signal in MosP-positive and WT newborn and adult mice. (C) EGFP ﬂuorescence in tails of mice carrying MosP and MosIR transgenes is not
reduced. Bright signal in some MosP-positive tails (e.g. ﬁrst on the left in the top row) is caused by the lack of pigmentation of the tails. The MosP
tail on the left in the lower row belongs to an F1 animal where we observed a spontaneous transcriptional silencing accompanied by DNA
methylation of the MosP promoter (Supplementary Figure S4). All images were obtained using the same settings. (D) EGFP signal in tail,
kidney, brain and oocytes of MosP, MosIR and MosP & MosIR mice. Organs were collected from siblings of one litter and their images were
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and the b-actin core promoter (Figure 4A). The inserted
sequence had a minimal effect on the activity of the pro-
moter as estimated by FACS analysis of cultured cells
transfected by equimolar amounts of MosP and the paren-
tal pCAGEGFP plasmid devoid of Mos insertion (data
not shown).
Transgenic mice carrying the MosP transgene displayed
strong EGFP expression (Figure 4B). In the F1 progeny of
the MosP founder male and a wild-type female, we
observed one case of spontaneous silencing of the
reporter, which was accompanied by DNA methylation
of the Mos sequence in the promoter (Figure 4C and
Supplementary Figure S4). This event suggested that the
transgene is prone to silencing involving epigenetic
changes to the Mos sequence in the promoter. However,
when MosP animals were crossed with MosIR animals,
the MosP reporter was never silenced in the presence of
the MosIR transgene (Figure 4C and D). These results
showed that the MosIR transgene did not induce tran-
scriptional silencing of homologous sequences in somatic
cells. Likewise, siRNAs generated in oocytes and early
embryos did not induce transcriptionally repressive chro-
matin at the MosP promoter, which would be propagated
into the soma. These results expand the list of observa-
tions that question the nature of a putative mammalian
RNA silencing pathway, which would employ siRNAs to
induce transcriptionally silent chromatin in trans, a
process commonly observed in plants (64–66).
MosIR expression does not induce the IFN response in
somatic cells
It is generally believed that long dsRNA causes
sequence-independent effects in somatic cells due to the
activation of a complex set of pathways generally
referred to as the IFN response. However, it is unlikely
that the MosIR transgene induced the typical IFN
response because the MosIR mice developed normally
and showed no obvious phenotype. We used qPCR to
analyze transcriptional activation of several genes (Iﬁt1,
Oas1, Pkr, Ddx58) associated with the IFN response in the
brain, kidney, liver and spleen (Figure 5A). Except for
Iﬁt1 in the brain (3.6-fold up) and Oas1 in the liver
(increased in one of the three animals), we did not ﬁnd
increased expression of ISGs. Together, these data sug-
gested that the MosIR transcript did not elicit a general
IFN response in somatic cells of the MosIR mice.
To further examine IFN activation by the MosIR trans-
gene, we performed a series of transfections of the MosIR
plasmid into 293 cells and analyzed several common
markers of the IFN response. When 293 cells were exa-
mined 48 h post-transfection (this time point was chosen
to emulate the situation in transgenic mice where MosIR
was continuously expressed), there was little, if any, induc-
tion of ISGs even at very high doses of MosIR. In control
experiments, we could detect up-regulation of several
ISGs in response to poly I:C, a commonly used ISG
inducer (Figure 5B). Likewise, phosphorylation of PKR,
a common marker of response to dsRNA, was seen
only at very high doses of the transfected MosIR vector
(Figure 5C).
PKR
PHOS-PKR
b-Tubulin
0 100 1800
no
DNA500
poly 
I:C
b-Tubulin
A
D
0
1
2
3
4
5
6
Ifit1 Oas1 Pkr Ddx58
Brain
Kidney
Liver
Spleen
0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
TRAF IRF1 NMI GCH1 C1S IFIT1 PKR DDX58
R
el
at
ive
 e
xp
re
ss
io
n
MosIR50
MosIR500
poly I:C
B
C
R
el
at
ive
 e
xp
re
ss
io
n
Figure 5. Analysis of the IFN response genes in mice and cell lines.
(A) Analysis of expression of IFN stimulated genes (ISGs) Iﬁt1, Oas1,
Pkr and Ddx58 in different tissues of MosIR mice. The expression was
estimated by qPCR and is shown relative to wild-type siblings. For
each gene, samples from three MosIR animals were analyzed in dupli-
cates. Hprt was used as an internal standard. Error bars=SEM.
(B) Analysis of expression of ISGs in 293 cells transfected with 50
and 500 ng (per well in a 24-well plate, the total amount of the trans-
fected DNA was kept constant by adding pCAGEGFP DNA) of the
MosIR plasmid 48 h after transfection. The expression was estimated by
qPCR and is shown relative to 293 cells transfected with 100 ng/well of
the pCAGEGFP plasmid. For comparison, ISGs were stimulated by
adding poly I:C to the media. HPRT1 was used as an internal standard.
The experiment was performed in triplicates. Error bars=SEM.
(C) Western blot analysis of induction of PKR phosphorylation by
the MosIR plasmid. Cells in 6-well plates were transfected with 100,
500 or 1800 ng of the MosIR plasmid and harvested for western blot
analysis 24 h after transfection. The total amount of the transfected
DNA was adjusted to 2 mg in all samples by adding corresponding
amount of pCAGEGFP DNA. The majority of transfected cells
showed green ﬂuorescence (data not shown), toxicity of the MosIR
to the cells was not apparent. Poly I:C was added to the media to a
ﬁnal concentration of 1 mg/ml and it was apparently toxic to the cells.
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To assess in more detail the potential of the MosIR
transgene to induce ISGs, we performed microarray
analysis of 293 and HeLa cells transfected with the same
amount of the MosIR plasmid as in the earlier described
SOLiD analysis (Figure 6). Clustering analysis based on
differentially expressed genes suggested that there was no
common transcriptome signature in cells expressing
dsRNA (Figure 6A). Overall, the number of genes with
altered expression upon transfection of the MosIR
plasmid was rather small and only 19 probe sets (corres-
ponding to 17 genes) were changed more than 2-fold in
both cell lines (Figure 6B and C and Supplementary Table
SI). Furthermore, detailed examination of differentially
expressed genes in 293 and HeLa cells revealed little, if
any, evidence for the activation of the IFN pathway
(Figure 6D and Supplementary Table SII). This con-
trasted with our earlier results where siRNA transfection
into 293 cells caused a strong up-regulation of many ISGs
(67). It should be noted that we have observed
up-regulation of a limited set of genes related to IFN ac-
tivation in HeLa cells (IRF1, IRF7, NFKB1, cytokines
IL1A, CCL20, CXCL3 and TNF/related genes TRAF1
and TNFAIP3, Supplementary Table SII). However, the
transcriptome changes in HeLa cells were small and did
not resemble typical transcriptome changes induced either
by dsRNA (18) or caused by siRNA transfection in 293
cells (67) (Figure 6C and D).
Taken together, our data show that somatic cells
tolerated MosIR expression unexpectedly well. It
appears that the IFN response is only elicited when the
amount of expressed dsRNA reaches a certain threshold.
The tolerance to expressed dsRNA seems to be signiﬁcant,
considering the amounts of MosIR plasmid used in our
experiments.
Adenosine deamination of MosIR RNA
Adenosine deamination has been proposed to target
nuclear dsRNA and to oppose the RNAi pathway
[reviewed in Ref (68,69)]. To estimate levels of adenosine
deamination of MosIR transcripts in different cell types,
we analyzed the 30-end of the MosIR hairpin region and
neighboring 30 single-stranded overhang by cloning and
sequencing RT–PCR products (Figure 7). This procedure
identiﬁed edited adenosines as A/G conversions in the
sequence. We found a minimal number of A/G conver-
sions in MosIR RNA obtained from kidney, liver and
brain of transgenic mice (Figure 7; data not shown).
These A/G conversions were mostly found in the region
of the predicted RNA duplex indicating that the MosIR
dsRNA was likely to be edited (Figure 7).
It has been reported that editing induces nuclear reten-
tion. However, the editing frequency observed in our ex-
periments was much lower than editing frequencies
implicated in nuclear retention of edited dsRNA in
HeLa 293
Adar
Anxa1
Ascl3
Atf3
Birc2
Btn3a3
C1s
Cflar
Chn1
Gbp1
Gch1
Ifit1
Irf1
Irf2
Isg20
Mx1
Nfkb1
Nmi
Oas1
Tap1
Tfpi2
Tnfaip2
Tnfaip3
Tnfaip6
Traf1
HeLa 293
315 19 92 38 0 15
HeLa 293
>2-fold up >2-fold down
HeLa MosIR
HeLa MosIR
HeLa control
HeLa control
293 control
293 control
293 MosIR
293 MosIR
log2 average expression
0 2 4 6 8 10 12
-2
-1
0
1
2
3
4
5
lo
g 2
ex
pr
es
si
on
 c
ha
ng
e
14
log2 average expression
0 2 4 6 8 10 12
-2
-1
0
1
2
3
4
5
lo
g 2
ex
pr
es
si
on
 c
ha
ng
e
14
392aLeH
A B
C
D
Figure 6. Microarray analysis of HeLa and 293 cells expressing MosIR. Microarray analysis of HeLa and 293 cells transfected with MosIR plasmid
(MosIR) or pCAGEGFP plasmid (control). (A) A hierarchical clustering of microarray samples using probe sets differentially expressed (>2-fold
change) between MosIR and control samples in both lines shows good concordance of duplicates and clustering according to the cell type. This
suggests that there is not a common set of genes induced by MosIR in these two cell lines. (B) A minimal overlap of differentially expressed genes in
HeLa and 293 cells. Genes corresponding to commonly up-regulated probe sets are listed in Supplementary Table SI. (C) MA plots of HeLa and 293
transcriptome change upon MosIR expression document small and distinct changes in hybridization intensities of probe sets. The X axis shows
Affymetrix probe hybridization signal intensities (log2 average expression); the Y axis, shows relative changes in probe intensity between MosIR and
control samples. Each point represents one probe set. Red and blue color highlight probe sets signiﬁcantly up-regulated and down-regulated in the
other cell line. (D) Absence of dsRNA-induced transcriptome signature in HeLa and 293 cells expressing long dsRNA. Genes previously identiﬁed as
genes induced by dsRNA treatment are shown (18).
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Xenopus oocytes and mammalian cells (70). In addition,
editing analysis in nuclear and cytoplasmic fractions from
MosIR MEFs did not reveal a strong evidence for nuclear
retention. We have found only 3 of 24 clones and 1 of
23 clones containing A/G conversions in nuclear and
cytoplasmic fractions, respectively (Supplementary Figure
S5A). Although the low frequency of editing does not
allow for precise estimation of enrichment of MosIR in
the nuclear fraction, these data suggest that nuclear reten-
tion is not strong. We also examined the degree of editing
in MosIR transcripts found in the polysomal fraction of
MEF cells derived from the MosIR mice. We found that 5
of 23 clones from the polysomal fraction contained A/G
conversions (Supplementary Figure S5B–D). Edited
clones contained on average 14% of edited adenosines
(the most edited sequence had converted 24% of adeno-
sines). These data suggested that editing did not prevent
nuclear export and translation. Furthermore, consistent
with our results, endogenous human mRNAs with
edited 30-UTRs were found previously to associate with
polysomes (25).
Relatively abundant editing of MosIR RNA was ob-
served in 293 cells transfected with the MosIR plasmid.
It was evident in about one-third of sequenced clones
where, on average, 21% of adenosines were edited
(Figure 7). Consistent with previous studies on adenosine
deamination, A/G conversion was not randomly distri-
buted along the sequence, but showed speciﬁc sequence
preferences (71,72). These data further strengthen our
conclusion that MosIR transcript forms dsRNA in vivo.
However, editing apparently affects only a fraction of
MosIR dsRNA formed in somatic cells. First, there was
no enrichment of editing in RNase T1-resistant MosIR
RNA from transgenic MEFs (data not shown). Second,
the frequency of A/G conversions in putative MosIR
siRNAs was comparable with the editing observed in
longer MosIR transcripts (Figures 7 and 8). Analysis of
SOLiD data from 293 cells showed that 15% of MosIR-
derived small RNAs of 21–23 nt in length contained A/G
conversions, while the conversion rate was negligible in
small RNAs of other lengths or EGFP sequence-derived
ones (Figure 8).
The low A/G conversion rate observed in MosIR-
derived small RNAs of other lengths than putative Dicer
products is presumably due to increased stability of edited,
Dicer-produced, siRNAs. Although we cannot exclude
that editing of siRNAs takes place after Dicer processing,
this scenario seems less likely than editing of the Dicer
substrate. Dicer-mediated cleavage is coupled with RISC
loading (73) and there is no biochemical evidence suggest-
ing the association of ADAR with the RISC (74).
In summary, our data suggest that the MosIR forms
dsRNA in vivo and that a fraction of dsRNA is edited.
Since editing frequency is similar in MosIR transcripts
and siRNAs derived from them, we conclude that Dicer
processes a small fraction of the MosIR dsRNA hairpin
regardless of whether they are edited or not. Therefore, the
low amount of MosIR siRNAs in somatic cells is likely to
be caused by inefﬁcient processing of dsRNA by Dicer
with editing having, at best, a secondary role as a factor
responsible for the ineffective formation of endogenous
siRNAs. While editing of MosIR dsRNA apparently
does not appear to interfere with Dicer processing, it
could still negatively inﬂuence efﬁciency of RNAi, since
editing changes the siRNA substrate speciﬁcity.
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Figure 7. Analysis of adenosine deamination of MosIR RNA.
Adenosine deamination was analyzed by cloning RT–PCR products
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CONCLUSIONS
We have established a transgenic mouse model that ubi-
quitously expresses a long RNA hairpin. There are several
independent lines of evidence suggesting that expression of
the MosIR transgene in mammalian cells produces
dsRNA in vivo. At the same time, it appears that
somatic cells are able to reduce dsRNA formation,
either by preventing dsRNA duplex formation or by un-
winding it. In contrast to the common view that dsRNA in
mammalian somatic cells imparts a detrimental effect, we
did not observe any typical sequence-independent
response associated with activation of the IFN pathway.
Our study suggests that long dsRNA structures in cellular
mRNAs are well tolerated and activate the IFN system
only at very high concentrations. Under normal condi-
tions, such dsRNA-containing mRNAs are partially
edited and poorly processed by Dicer in somatic cells,
perhaps because somatic cells lack a factor facilitating
siRNA biogenesis. Effective RNAi has been observed
only in oocytes, providing yet more evidence that the
female germline is a privileged tissue in terms of directing
dsRNA into the RNAi pathway. Altogether, our data
support a model that the effects of long dsRNA in mam-
malian cells are inﬂuenced by additional factors, which
determine how cells respond to such dsRNA. These
factors certainly involve the cellular history of dsRNA
and structural features, such as 50-end modiﬁcations and
length of sequences ﬂanking dsRNA stem.
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